missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ARHGAP24 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5104104
This item is not returnable.
View return policy
Description
Antibody detects endogenous levels of total RHG24.
Rho GTPase-activating protein involved in cell polarity, cell morphology and cytoskeletal organization. Acts as a GTPase activator for the Rac-type GTPase by converting it to an inactive GDP-bound state. Controls actin remodeling by inactivating Rac downstream of Rho leading to suppress leading edge protrusion and promotes cell retraction to achieve cellular polarity. Able to suppress RAC1 and CDC42 activity in vitro. Overexpression induces cell rounding with partial or complete disruption of actin stress fibers and formation of membrane ruffles, lamellipodia, and filopodia. Isoform 2 is a vascular cell-specific GAP involved in modulation of angiogenesis.
Specifications
| ARHGAP24 | |
| Polyclonal | |
| Unconjugated | |
| ARHGAP24 | |
| 0610025G21Rik; Arhgap24; Down-regulated in nephrectomized rat kidney #2; DR-NR#2; Filamin-A-associated RhoGAP; FILGAP; p73; p73RhoGAP; RAC1- and CDC42-specific GTPase-activating protein of 72 kDa; RCGAP72; RC-GAP72; Rho GTPase activating protein 24; rho GTPase-activating protein 24; rhoGAP of 73 kDa; Rho-type GTPase-activating protein 24; Sarcoma antigen NY-SAR-88; si:ch211-65i12.2 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 231532, 305156, 83478 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q5U2Z7, Q8C4V1, Q8N264 | |
| ARHGAP24 | |
| A synthesized peptide derived from human ARHGAP24(Accession Q8N264), corresponding to amino acid residues S573-A623. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction